Objective: The objective of this study was to determine the effects of disodium ascorbyl phytostanyl phosphate (DAPP), a novel hydrophilic phytostanol analogue, on energy homeostasis, including body weight and intestinal energy absorption, and plasma triglyceride concentrations, in hamsters. Methods: Male Golden Syrian hamsters (n ¼ 50) were fed for 5 weeks with experimental diets varying in cholesterol and phytostanol content. Diets included (i) non-cholesterol (semipurified diet without added cholesterol), (ii) cholesterol-control (semipurified diet with 0.25% cholesterol), (iii) stanol (cholesterol-control with 1% free phytostanols), (iv) DAPP 0.7% (cholesterol-control with 0.71% DAPP) or (v) DAPP 1.4% (cholesterol-control with 1.43% DAPP). Fecal samples were collected continuously for 3 days on week 3, and fecal energy output was measured by bomb calorimetry. Results: Hamsters fed 1.4% DAPP gained less (Po0.05) weight than hamsters fed non-cholesterol and stanol diets. Diets had no effect on total food consumption or gross energy intake after 5 weeks, but lower (Po0.05) weekly food consumptions in hamsters fed 1.4% DAPP were observed at weeks 1 and 2 of the experiment in comparison to animals fed the non-cholesterol diet. In comparison to non-cholesterol and cholesterol-control diets, DAPP 1.4% increased (Po0.01) fecal energy output by 47 and 46%, respectively. In hamsters supplemented with 1.4% DAPP, plasma triglyceride concentrations were 45% lower (Po0.05) than in cholesterol-control fed hamsters. Furthermore, plasma triglyceride levels in the DAPP 1.4% group was 49% lower (Po0.01) than in the stanol group, despite the fact that both diets contained equivalent amounts of phytostanols. The lower concentration of DAPP (0.7%) also reduced plasma triglycerides (Po0.05) compared with the stanol diet. Conclusion: Stanol-ascorbate decreases body weight gain in hamsters, likely due to lower energy absorption at the intestinal level. In addition to its previously observed powerful cholesterol-lowering effect, DAPP has a hypotriglyceridemic function in hamsters.
Introduction
Elevated plasma cholesterol concentrations, as well as high triglyceride levels, are associated with an increased risk of cardiovascular diseases. Plant sterols, also called phytosterols, are among the dietary components that exert a beneficial impact on hypercholesterolemia. Phytosterols are widely distributed in plant foods such as vegetable oils, nuts, seeds and grains. Phytosterols and their saturated derivatives, phytostanols, have been shown to efficiently decrease plasma total and low-density lipoprotein (LDL)-cholesterol concentrations in human [1] [2] [3] and animal models. 4, 5 Recent meta-analyses demonstrated that a dose of 1-2 g of plant sterols or stanols per day lowers serum LDL-cholesterol by 8-12% in humans. 1, 3 In order to enhance the cholesterol-lowering effect of plant stanols, a novel water-soluble phytostanol ester, in which phytostanols are covalently bound to ascorbic acid (disodium ascorbyl phytostanyl phosphates: DAPP), was recently developed. It has been demonstrated that DAPP had a more potent hypocholesterolemic effect than unesterified phytostanols in apolipoprotein E knockout mice. 6 In addition to its remarkable effect on circulating cholesterol levels, some animal studies have suggested that DAPP may reduce body weight 7, 8 and plasma triglyceride concentrations. 6, 7 Thus, DAPP could hold potential as an anti-obesity agent. However, the mechanisms involved in the action of DAPP on body weight and triglyceride levels are still unknown. Body energy storage is modulated by a balance of factors that include energy intake and expenditure. An alteration in food consumption does not appear to be the main mechanism implicated in the reducing effect of DAPP on body weight, as studies have shown no effect 8 or inversely increased food consumption following DAPP supplementation. 7 Therefore, it seems reasonable to suppose that the lowering effect of DAPP on body weight is attributable to an inhibition of energy uptake in the intestinal tract. Our working hypothesis was that DAPP would lower body weight by inhibiting intestinal energy absorption. The aim of the present study was therefore to examine the effects of DAPP on body weight and intestinal energy absorption, as well as plasma triglyceride concentrations in comparison with the effects of a parent compound, unesterified phytostanols.
Methods

Animals and diets
A total of 50 male Golden Syrian hamsters weighing 90-110 g (Charles River Laboratories, Montreal, QC, Canada) were randomly divided into five groups. Hamsters were housed individually in stainless-steel colony cages with a wire mesh floor. The light period of 12 h began at 0700 hours. Room temperature was set at 20711C. During an acclimatization period of 2 weeks, hamsters had free access to water and were fed ad libitum a plain pelleted chow diet (Charles River Laboratories). Hamsters were then fed for 5 weeks with one of the five semipurified experimental diets that were prepared every 2 weeks and stored at À201C. Dietary composition is shown in Table 1 . To produce good growth rates in the hamsters, a diet that has been previously used in our experiments [9] [10] [11] was given to the animals in order to favor weight gain. The composition of the experimental diets conformed to AIN-76 formulation. 12 All diets contained 5% (wt/wt) fat, provided in the form of a mix of beef tallow and safflower oil to yield a polyunsaturated to saturated fatty acid ratio of 0.4. The diet was fed in stainlesssteel holders attached to the floor of each cage. All diets, except the non-cholesterol diet, contained 0.25% cholesterol. No phytostanols were added to the non-cholesterol and the cholesterol-control diets, while phytostanol diets contained either 1% of unesterified phytostanol (stanol), 0 The entire fecal output was collected for 3 consecutive days during week 3 of the experiment and freeze-dried. After grinding and mixing the freeze-dried feces, energy content was determined by bomb calorimetry (Adiabatic calorimeter 1241, Parr Instrument). Benzoic acid was used as a combustion standard. It has recently been reported that very small amounts of plant stanols are absorbed in the human intestine. 13 Since the experimental diets contained different amounts of stanols (0.5% or 1%), the amount of stanols consumed by hamsters in different groups may have affected the stanol content in feces and the fecal energy outputs. Thus, values of fecal energy outputs were corrected for consumed stanol amounts. The corrections were based on food consumption during the observation period and diet composition. The energy density of each dietary compound was determined by calorimetry, and it was assumed that stanols were not absorbed in the intestine. Digestible energy was calculated for each animal as the difference between gross energy consumed and fecal energy output. Blood and tissue sample collection and plasma lipid analyses After 5 weeks of feeding with the experimental diets, hamsters were deprived of food overnight prior to anaesthetization with halothane and decapitated. Blood samples were immediately collected by decapitation into tubes with EDTA and placed on ice. Plasma and RBC were separated by centrifugation at 1300 rpm for 15 min. Plasma samples were stored at À801C until further analysis. The liver was carefully removed and weighed. Plasma triglyceride concentrations were measured in duplicate by enzymatic method using the Trig/GB kit from Roche Diagnostics (Laval, QC, Canada). 14 
Data analysis and statistics
Results are expressed as means7standard error of the mean. Food consumption and body weight data were submitted to a two-way repeated measures analysis of variance (ANOVA) to identify treatment by time interactions. For cases in which the interaction was significant, subsequent comparisons were conducted using one-way ANOVA at each week, followed by Tukey-Kramer's tests to identify differences among diet groups. The remaining data were subjected to a one-way ANOVA to determine main diet effects. When statistically significant diet effects were detected, TukeyKramer's tests were performed. The relationships between variables were tested using a Pearson's correlation coefficient. Statview for Windows version 5.0.1 (SAS Institute Inc., Cary, NC, USA) was used for statistical analyses.
Results
Food consumption and energy intake Table 2 shows average food consumption and gross energy intake data as well as total values of each parameter during the experiment. Diets had no significant effect on either average food consumption or gross energy intake over the entire feeding period, and there were no significant differences in total food consumption or gross energy intake among the groups. However, lower (Po0.05) weekly food consumption values in hamsters fed 1.4% DAPP were observed at weeks 1 and 2 of the experiment, compared to animals fed non-cholesterol diet ( Figure 1 ).
Body weight gain and fecal energy output Despite DAPP 1.4%-fed hamsters continuously showing lower body weight at each week, no significant difference was detected in weekly body weights among treatment groups. However, at the end of the 5-week experiment, hamsters fed with the 1.4% DAPP diet had gained less weight than hamsters fed with the non-cholesterol (Po0.01) and stanol (Po0.05) but not other diets ( Figure 2 ). As shown in Figure 3 , compared with non-cholesterol and cholesterol-control diets, 1.4% DAPP diet increased (Po0.01) fecal energy output. When fecal energy output was corrected for estimated plant stanol output (assuming that plant stanols were not absorbed in the intestine), a tendency was observed in the variance across the treatment groups (P ¼ 0.06). Although not statistically significant, the corrected energy output was 25% (P ¼ 0.14) and 26% (P ¼ 0.11) higher in hamsters fed 1.4% DAPP compared to hamsters fed the cholesterol-control and stanol diets, respectively. Positive correlations were observed between body weight gain during week 3 and digestible energy intake at the third week (calculated as gross energy intakeÀfecal energy output) ( Figure 4 , r ¼ 0.66, Po0.0001).
Plasma triglyceride concentrations
Effects of various phytosterol preparations on plasma triglyceride levels are shown in Figure 5 . While the Non-chol, control diet without added cholesterol; Chol-control, control diet with 0.25% added cholesterol; Stanol, chol-control with added 1% phytostanols; DAPP 0.7%, chol-control with added 0.71% disodium ascorbyl phytostanyl phosphates; DAPP 1.4%, cholcontrol with added 1.43% disodium ascorbyl phytostanyl phosphates. Plant stanol ascorbate decrease energy absorption N Ebine et al unesterified stanol-containing diet did not affect plasma triglyceride levels in comparison with the cholesterolcontrol diet, DAPP at a concentration of 1.4% resulted in 45% lower (Po0.05) plasma triglyceride levels compared with the cholesterol-control. Moreover, in 0.7% DAPP-and 1.4% DAPP-fed hamsters, plasma triglyceride levels were decreased by 42% (Po0.05) and 49% (Po0.01), respectively, compared to hamsters fed unesterified phytostanols.
Liver weight
The relative liver weights (g/100 g body weight) after the 5-week feeding period were 4.3570.10 g, 5.2070.15 g, 4.8670.17 g, 4.4270.17 g and 4.4170.12 g in non-cholesterol, cholesterol-control, stanol, DAPP 0.7% and DAPP 1.4% group, respectively. No difference in relative liver weight was observed between the cholesterol-control-and the stanol-fed group. However, relative liver weights were lower in hamsters fed non-cholesterol (Po0.01), 0.7 (Po0.05) and 1.4% DAPP diets (Po0.01) compared to hamsters fed the cholesterol-control diet. A positive correlation was observed between relative liver weights and plasma triglyceride concentrations (r ¼ 0.41, Po0.01).
Discussion
The present study examined for the first time the effects of a plant sterol derivative on intestinal energy absorption in relation to body weight. Data show that body weights of hamsters fed DAPP at 1.4% were decreased in comparison with those of hamsters fed with other diets after the 5-week Body weight gain during week 3 (g) Digestible energy at third week (kcal/day) Figure 4 Correlations between digestible energy intake at third week and body weight gain during week 3 (n ¼ 50). Non-chol, control diet without added cholestrol; Chol-control, control diet with 0.25% added cholesterol; Stanol, chol-control with added 1% phytostanols; DAPP 0.7%, chol-control with added 0.71% disodium ascorbyl phytostanyl phosphates; DAPP 1.4%, chol-control with added 1.43% disodium ascorbyl phytostanyl phosphates.
Plant stanol ascorbate decrease energy absorption N Ebine et al experiment, resulting in lower body weight gain in 1.4% DAPP-fed hamsters compared to stanol-and non-cholesterolfed animals. Most previous studies on DAPP have targeted effects on circulating cholesterol levels, but two of those animal studies reported unexpected lower body weights by the supplementation of DAPP accompanied with inconsistent relationship to food consumption. 7, 8 In a 4-week study, a decrease in body weight was observed in gerbils fed 1 or 2% DAPP incorporated in experimental diets, without any effect on food consumption. 8 Over an 8-week experimental period, consumption of 4% DAPP incorporated in the diet resulted in lower body weights in gerbils in comparison to no DAPP treatment. 7 Interestingly, food consumption was reduced in gerbils fed 4% DAPP at the beginning of the treatment, but was increased at the end of the 8-week trial and showed higher values than that of gerbils fed no DAPP. 7 Our observation of a higher fecal energy content in hamsters fed 1.4% DAPP after 3 weeks of treatment compared with hamsters fed cholesterol-control and non-cholesterol diets suggests that the decreasing effect of DAPP on body weight may be due to a lower energy intake at the level of the intestinal tract. After adjustment for the estimated plant stanol excretion, fecal energy output was over 13 and 25% higher in both low and high concentration of DAPP-fed hamsters, respectively, than in the other three groups, but this effect did not reach statistical significance. In contrast with 1.4% DAPP, and despite the equivalent amount of plant stanols in the diet, the stanol diet did not increase fecal energy output compared with cholesterol-control and noncholesterol diets (Figure 3) . Thus, we conclude that inhibiting energy absorption and lowering body weight functions are specific for phytostanol esterified with ascorbic phosphates. Moreover, the significant correlation observed between digestible energy at the third week and body weight gain during week 3 ( Figure 4) indicates that intestinal energy absorption is an important factor regulating body weight. Therefore, the results of the present study suggest that a significant underlying mechanism by which DAPP affects body weight is by interfering with energy absorption in the digestive tract. To our knowledge, no other studies have shown the effects of plant sterol or stanol analogues in reducing absorption of energy substrates. Both humans 3 and hamsters [15] [16] [17] absorb approximately 50% of dietary cholesterol in the intestinal tract. It is known that DAPP, as well as traditional plant sterols, inhibit intestinal cholesterol absorption. 1, 3, 18, 19 Therefore, enhanced fecal energy output may be a consequence of increased fecal cholesterol excretion due to the blockage of absorption. However, it is difficult to associate the enhanced energy output to increased cholesterol excretion. Indeed, even if DAPP completely inhibited the cholesterol absorption, cholesterol excretion would contribute less than 0.1 kcal/day increase in fecal energy that is in accordance with theoretical calculations. In fact, in animals fed stanol, which also lowers cholesterol absorption, there was no detectable difference in average fecal energy output compared with hamsters fed the cholesterol-control diet (Figure 3b ). Therefore, it is possible that enhanced excreted energy by DAPP treatments could be due to inhibited absorption of other energy substrate(s).
Based on results from a previous study, 7 it could be hypothesized that a decrease in gross energy intake may be responsible for the action of DAPP on body weight. In our study, an inhibition of food consumption by the higher concentration of DAPP was observed at only the early stages of the experiment in comparison with the non-cholesterol diet ( Figure 1 ). Decreased gross energy intake, therefore, may be one of the factors contributing to the body weight lowering action of DAPP in our animal model. On the other hand, this effect of DAPP on food consumption had disappeared at the middle of the feeding period, despite DAPP being continuously supplied to the animals until the end point. In addition, there was no significant difference in food consumption between hamsters fed 1.4% DAPP and hamsters fed stanols at any time period, while body weight gain was decreased in 1.4% DAPP-fed hamsters compared with stanol-fed animals. These results suggest that a decrease in food consumption may not be the sole factor in the lowering effect of DAPP on body weight gain and that other mechanisms may be implicated as well. Although corrections for spillage were made, it should be noted that precise measurement of food consumption is difficult; therefore, this might have contributed to the inconsistent effect of DAPP on food consumption in previous studies as well as in the present experiment. A prospective study investigating the effects of DAPP on appetite-regulating hormones and metabolism regulators would help to confirm the hypothesis Plasma triglycerides (mmol/l) Plant stanol ascorbate decrease energy absorption N Ebine et al of a body weight lowering effect of DAPP through reduced food consumption. The potential lowering effect of DAPP on plasma triglyceride concentrations has been previously reported. In gerbils, a concentration of 4% DAPP added to drinking water over an 8-week period decreased triglyceride levels in comparison with a control diet containing no DAPP. 7 However, in a shorter (4-week) study involving the same species, no effect was observed on circulating triglycerides with a dose of 2% DAPP administrated into the diet. 8 In another study in apolipoprotein E-deficient mice, however, a 2% DAPP diet reduced plasma triglyceride concentrations after 4 and 8 weeks in comparison with control animals, but this triglyceride lowering effect disappeared at 12 weeks. 6 Nevertheless, in the present study with hamsters, a hypotriglyceridemic effect of DAPP was observed with lower concentrations in the diet (1.4%) than in previous experiments, while unesterified stanols had no such effect ( Figure 5 ). In fact, even a concentration of 0.7% DAPP resulted in lower triglyceride levels compared to unesterified stanols. These results suggest that the hypotriglyceridemic effect of DAPP may vary depending on the animal species and the administration (in water or in diet). In our study, the hamster model appeared to be a good responder to the hypotriglyceridemic effect of a diet supplemented with DAPP. The hamster model was chosen because of its similarities with humans in terms of lipid metabolism. 20 In humans, a positive correlation has been observed between body fat mass and plasma triglycerides. 21, 22 Hence, the triglyceride-lowering effect of DAPP observed in the present study may be related to its decreasing effect on body weight. Triglyceride levels are modulated by the rate of synthesis and secretion of triglycerides by the liver, and by their intravascular hydrolysis. In the present study, relative liver weights of hamsters fed with both concentrations of DAPP were lower than in the cholesterol-control group. As well, a significant correlation between relative liver weights and plasma triglyceride concentrations was observed. These findings suggest a lower accumulation of triglycerides in the liver, and perhaps a decreased secretion rate, in DAPP-fed hamsters. It is important to note that the lower concentration of DAPP (0.7%) also resulted in decreased plasma triglyceride concentrations compared to the stanol diet, although no alteration on weekly body weight and weight gain was observed throughout the study. In addition, an unclear linkage between decreased plasma triglycerides and lowered body weight was observed in other animal species. 6, 8 These outcomes must imply existence of additional mechanisms at play in reducing plasma triglycerides with DAPP. As traditional forms of plant sterols as well as their esters are fat soluble, they were previously incorporated into the diets by mixing and integrating with dietary fat or oil. 1, 23, 24 One obvious physical difference of chemically synthesized DAPP from other standard forms of plant sterols is its higher water solubility. DAPP can therefore be easily incorporated to non-fat foods and water as an additive agent. Even supplied in drinking water, DAPP has already been shown to have a beneficial effect on circulating lipid levels and to inhibit intestinal cholesterol absorption in animals. 6, 7, 19 Clinical studies are required not only to establish the appropriate applications of DAPP for humans but also to determine the effective dosage. Obesity is a major risk factor for morbidity and mortality, and a series of pharmacologic approaches are now available to help manage this problem. 25, 26 Orlistat is one of the most striking drugs in this field; it lowers body weight by inhibiting intestinal triglyceride absorption. 27 Dietary triglyceride hydrolysis in the intestinal lumen is decreased by inhibited gastric and pancreatic lipases activities; unabsorbed triglycerides are then excreted fecally. Several clinical trials have shown favorable effects of Orlistat on weight loss and serum lipids. [28] [29] [30] Orlistat has also been shown to lower cholesterol concentrations in human 31 by inhibiting dietary cholesterol absorption 32 the same way DAPP does in animals. [6] [7] [8] 18, 19 It has been reported that 1% (wt/wt) and 2% DAPP in the diet as well as 2 and 4% DAPP in drinking water decrease total and LDL-cholesterol levels in gerbils. 7, 8 Recently, Lukic et al. 6 reported that in comparison with a diet containing 0.2% cholesterol and no DAPP, a 4-week administration of DAPP at a dose as low as 0.5% reduced total cholesterol concentrations by approximately 75% in cholesterol-fed apolipoprotein E-deficient mice. Owing to the similarity of both Orlistat and DAPP in altering circulating lipids and cholesterol absorption, there is a possibility that the hypotriglyceridemic action of DAPP may be regulated by similar mechanisms as Orlistat. 18, 19 At present, the action of DAPP on the intestinal energy substrate absorption has not been elucidated. However, lower liver weight and plasma triglyceride levels observed in the present study in hamsters fed DAPP may be partially caused by reduced triglyceride absorption and/or lower body weight, consequent to decreased energy absorption in the intestine. Further comprehensive studies are required to gain direct evidence and investigate the mechanisms that might explain the possible anti-obesity effect of DAPP. In summary, results from the present study illustrate that an ascorbyl phytostanyl phosphate plant stanol derivative decreases body weight gain in hamsters, which may be due to a reduction in energy absorption at the intestinal level. The findings suggest that ascorbyl phytostanyl phosphate may be useful not only for improving circulating cholesterol profile [6] [7] [8] but also for treating hypertriglyceridemia and obesity.
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